Alternatives to Allergan

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing novel therapeutic approaches for ocular diseases.

Global pharmaceutical company focused on developing and manufacturing medicines.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

AI-powered platform accelerating biological research and drug discovery.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.